Meridian Bioscience Inc (VIVO)-製薬・医療分野:企業M&A・提携分析

GlobalDataが発行した調査報告書(DATA8013393)
◆英語タイトル:Meridian Bioscience Inc (VIVO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013393
◆発行会社(リサーチ会社):GlobalData
◆発行日:2017年11月28日
◆ページ数:44
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。GlobalData社の概要及び新刊レポートはこちらでご確認いただけます。

【レポートの概要】

Summary
Meridian Bioscience Inc (Meridian) is a fully integrated life science company that carries out the development, manufacturing and distribution of diagnostic test kits for gastrointestinal, viral, respiratory, and parasitic infectious disease indications. It also manufactures bulk antigens, antibodies, purified reagents, nucleotides and related products for use in research and diagnostic manufacturing. Meridian develops proteins and other biological materials for use in biotechnology research for new drugs and vaccines. It offers several diagnostic tests and transport media for prenatal care, respiratory infections and organ transplant infections, among other infectious disease areas. Meridian offers its products to hospitals, clinics, veterinary testing centers, reference laboratories, research centers, physician offices and diagnostics manufacturers. The company has presence in the US, Europe, Africa and the Middle East through direct offices and subsidiaries. Meridian is headquartered in Ohio, the US.

Meridian Bioscience Inc (VIVO) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Meridian Bioscience Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Meridian Bioscience Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Meridian Bioscience Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Meridian Bioscience Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Meridian Bioscience Inc, Medical Devices Deals, 2011 to YTD 2017 9
Meridian Bioscience Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Meridian Bioscience Inc, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Meridian Bioscience Enters into Licensing Agreement with University of Tennessee for Electrokinetic Sensor Technology 11
Microbix Biosystems Enters into Distribution Agreement with Meridian Life Science 12
Equity Offering 13
Meridian Bioscience Files Registration Statement For A Public Offering Of Securities 13
Meridian Bioscience Inc – Key Competitors 14
Meridian Bioscience Inc – Key Employees 15
Meridian Bioscience Inc – Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Recent Developments 18
Financial Announcements 18
Oct 19, 2017: Meridian Bioscience Comments on Preliminary Fiscal 2017 Operating Results and Provides Fiscal 2018 Revenue and Earnings Guidance 18
Jul 27, 2017: Meridian Bioscience Reports Third Fiscal Quarter 2017 Operating Results 20
Apr 27, 2017: Meridian Bioscience Reports Second Quarter 2017 Operating Results 23
Apr 27, 2017: Meridian Bioscience Reports Second Quarter 2017 Operating Results, Declares Regular Cash Dividend, and Reaffirms Fiscal 2017 Guidance 25
Nov 10, 2016: Meridian Bioscience Reports Fourth Quarter and Full-Year Operating Results 27
Oct 18, 2016: Meridian Bioscience Comments on Preliminary Fiscal 2016 Operating Results and Provides Fiscal 2017 Revenue and Earnings Guidance 29
Jul 28, 2016: Meridian Bioscience Reports Third Quarter 2016 Operating Results, Declares Regular Cash Dividend, and Updates Fiscal 2016 Guidance 31
Apr 28, 2016: Meridian Bioscience Reports Second Quarter 2016 Operating Results 33
Jan 27, 2016: Meridian Bioscience Reports First Quarter 2016 Operating Results 35
Corporate Communications 37
Oct 10, 2017: Meridian Bioscience Appoints Jack Kenny as Chief Executive Officer 37
Aug 08, 2017: Meridian Bioscience Elects John Rice to the Board of Directors 38
May 10, 2017: Meridian Bioscience Engages Korn Ferry to Conduct CEO Search as John A. Kraeutler Announces Plans to Retire 39
Legal and Regulatory 40
Oct 23, 2017: Meridian Bioscience Comments on FDA Press Statement Regarding Its Warning Letter Issued to Magellan Diagnostics 40
Jul 13, 2017: Meridian Bioscience Comments on Recent FDA Press Statement 41
Oct 03, 2016: Bioline is Certified to the ISO 13485 Quality Standard 42
Product News 43
Mar 03, 2016: Bioline Launches New EPIK miRNA Select Kits 43
Appendix 44
Methodology 44
About GlobalData 44
Contact Us 44
Disclaimer 44

List of Tables
Meridian Bioscience Inc, Pharmaceuticals & Healthcare, Key Facts, 2016 2
Meridian Bioscience Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Meridian Bioscience Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Meridian Bioscience Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Meridian Bioscience Inc, Deals By Therapy Area, 2011 to YTD 2017 8
Meridian Bioscience Inc, Medical Devices Deals, 2011 to YTD 2017 9
Meridian Bioscience Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Meridian Bioscience Enters into Licensing Agreement with University of Tennessee for Electrokinetic Sensor Technology 11
Microbix Biosystems Enters into Distribution Agreement with Meridian Life Science 12
Meridian Bioscience Files Registration Statement For A Public Offering Of Securities 13
Meridian Bioscience Inc, Key Competitors 14
Meridian Bioscience Inc, Key Employees 15
Meridian Bioscience Inc, Other Locations 16
Meridian Bioscience Inc, Subsidiaries 16

【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ Meridian Bioscience Inc (VIVO)-製薬・医療分野:企業M&A・提携分析(Meridian Bioscience Inc (VIVO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile)]についてメールでお問い合わせはこちらでお願いします。

◆H&Iグローバルリサーチのお客様(例)◆